A novel drug, retatrutide, is creating considerable anticipation in the field of weight management . This two-pronged injectable therapy works by mimicking the effects of two gut hormones, GLP-1 and GIP, which naturally regulate hunger and encourage feelings of contentment. Early clinical studies